Adaptive Biotechnologies Corp

Maps immune genetics for blood cancer diagnostics and drug discovery partnerships.

ADPT | NDAQ

Overview

Corporate Details

ISIN(s):: US00650F1093
LEI:
Country:: United States of America
Address:: 1165 EASTLAKE AVE E, 98109 SEATTLE
Website:: https://www.adaptivebiotech.com
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Adaptive Biotechnologies is a commercial-stage biotechnology company pioneering the field of immune medicine. The company's proprietary Immune Medicine Platform maps the genetics of the adaptive immune system by sequencing T-cell and B-cell receptors at scale. This technology enables two primary application areas: clinical diagnostics and drug discovery. Its key diagnostic product is a highly sensitive, next-generation sequencing (NGS)-based assay for the assessment of Minimal Residual Disease (MRD) in blood cancers, used in both clinical practice and drug trials. Additionally, Adaptive partners with pharmaceutical companies, providing rich immune receptor data and services to inform clinical trials and support the development of new therapeutics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Adaptive Biotechnologies Corp filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Adaptive Biotechnologies Corp

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Adaptive Biotechnologies Corp via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
GENFLOW BIOSCIENCES PLC Develops gene therapies to slow aging and treat age-related diseases in humans and dogs.	United Kingdom	GENF
GENINUS Inc. AI-powered genomic and multi-omics analysis for precision medicine and clinical partners.	South Korea	389030
genOway Develops custom genetically modified preclinical models for biopharma and academic research.	France	ALGEN
Genpact LTD Drives business transformation for enterprises using AI, data, and technology services.	United States of America	G
GenSight Biologics S.A. Developing gene therapies for neurodegenerative diseases of the eye and central nervous system.	France	SIGHT
GeoVax Labs, Inc. Developing vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms.	United States of America	GOVX
GEZİNOMİ SEYAHAT TURİZM TİCARET A.Ş. A travel agency offering online booking for transport, hotels, cultural tours, and cruises.	Türkiye	GZNMI
GIG Works Inc. Connects businesses with gig workers, offering staffing, BPO, IT, and coworking services in Japan.	Japan	2375
Globe Capital Limited An investment company providing global marketing and promotion services, focusing on UK businesses.	Cayman Islands	GCAP
GMO Research & AI, Inc. Market research tech providing access to 65M+ APAC consumer panelists for data-driven insights.	Japan	3695